$
3.650
-0.01(-0.273%)1D
  • Overview
  • Forecast
  • Valuation
  • Earnings
Line
Line
|
Candle
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
3.9292
Open
3.700
VWAP
3.68
Vol
115.96K
Mkt Cap
32.79M
Low
3.570
Amount
426.32K
EV/EBITDA(TTM)
--
Total Shares
128.43M
EV
39.03M
EV/OCF(TTM)
--
P/S(TTM)
78.79
Clene Inc. is a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis, Parkinson's disease, and multiple sclerosis. It specializes in the discovery, development, and commercialization of clean-surfaced nanotechnology (CSN) therapeutics. CNM-Au8, the lead asset, is a concentrated aqueous suspension of catalytically active, clean-surfaced, faceted gold nanocrystals. CNM-Au8’s mechanism of action targets mitochondrial dysfunction by catalyzing the production of nicotinamide adenine dinucleotide. Its CNM-ZnAg is a broad-spectrum antiviral, antibacterial agent comprised of zinc (Zn2+) and silver (Ag+) ions under development to treat infectious disease and to provide immune support for symptom resolution. Its CNM-AgZn17 is a gel polymer suspension of Zn2+ and Ag+ under development for the treatment of infectious diseases and to support wound healing.
Show More

Market Estimates

Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2025Q3
FY2025Q2
64.50K
-29.12%
--
--
59.50K
-31.61%
--
--
56.17K
-38.27%
--
--
Estimates Revision
The market is revising Downward the revenue expectations for Clene Inc. (CLNN) for FY2025, with the revenue forecasts being adjusted by -2.19% over the past three months. During the same period, the stock price has changed by 20.46%.
Revenue Estimates for FY2025
Revise Downward
down Image
-2.19%
In Past 3 Month
Stock Price
Go Up
up Image
+20.46%
In Past 3 Month
4 Analyst Rating
up Image
680.82% Upside
Wall Street analysts forecast CLNN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CLNN is 28.50 USD with a low forecast of 20.00 USD and a high forecast of 33.00  USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
4 Buy
0 Hold
0 Sell
Strong Buy
up Image
680.82% Upside
Current: 3.650
sliders
Low
20.00
Averages
28.50
High
33.00
Jones Trading
Justin Walsh
Strong Buy
Initiates
$30
2025-04-23
Reason
HC Wainwright & Co.
Joseph Pantginis
Strong Buy
Reiterates
$31
2025-04-08
Reason
D. Boral Capital
Jason Kolbert
Strong Buy
Maintains
$23
2025-04-08
Reason
HC Wainwright & Co.
Joseph Pantginis
Strong Buy
Reiterates
$31
2025-03-25
Reason
D. Boral Capital
Jason Kolbert
Strong Buy
Maintains
$23
2025-03-24
Reason
HC Wainwright & Co.
Joseph Pantginis
Strong Buy
Reiterates
$31
2025-03-24
Reason

Valuation Metrics

The current forward P/E ratio for Clene Inc. (CLNN.O) is -1.77, compared to its 5-year average forward P/E of -6.58. For a more detailed relative valuation and DCF analysis to assess Clene Inc. 's fair value, click here.

Forward PE

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-6.58
Current PE
-1.77
Overvalued PE
1.61
Undervalued PE
-14.77

Forward EV/EBITDA

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-1.42
Current EV/EBITDA
-2.67
Overvalued EV/EBITDA
-0.23
Undervalued EV/EBITDA
-2.60

Forward PS

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
443.34
Current PS
137.73
Overvalued PS
930.53
Undervalued PS
-43.85

Financials

Annual
Quarterly
FY2025Q1
YoY :
+10.96%
81.00K
Total Revenue
FY2025Q1
YoY :
-55.85%
-4.08M
Operating Profit
FY2025Q1
YoY :
-93.22%
-751.00K
Net Income after Tax
FY2025Q1
YoY :
-94.80%
-0.09
EPS - Diluted
FY2025Q1
YoY :
-29.35%
-5.01M
Free Cash Flow
FY2025Q1
YoY :
-3.55%
75.31
Gross Profit Margin - %
FY2025Q1
YoY :
+21.42%
-5.50K
FCF Margin - %
FY2025Q1
YoY :
-93.89%
-927.16
Net Margin - %
FY2025Q1
N/A
ROIC

Trading Trends

Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
9.3K
USD
6
3-6
Months
12.1K
USD
2
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
3
583.4K
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months

CLNN News & Events

Events Timeline

2025-06-30 (ET)
2025-06-30
08:03:36
Clene provides regulatory update following FDA Type C meeting
select
2025-05-07 (ET)
2025-05-07
08:07:27
Clene sees cash runway into 3Q25
select
2025-05-07
08:06:47
Clene reports Q1 EPS (9c), consensus (78c)
select
Sign Up For More Events

News

1.0
07-15Globenewswire
Presenting on Emerging Growth Conference 84 Day 2 on July 17; Register to live stream
4.0
06-30Benzinga
D. Boral Capital Maintains Buy on Clene, Maintains $23 Price Target
9.0
06-30Newsfilter
Clene Provides Regulatory Update Following Constructive FDA Type-C Meeting on Neurofilament Biomarker Analysis Plan and Confirms Two Additional FDA Meetings
Sign Up For More News

FAQ

arrow icon

What is Clene Inc. (CLNN) stock price today?

The current price of CLNN is 3.65 USD — it has decreased -0.27 % in the last trading day.

arrow icon

What is Clene Inc. (CLNN)'s business?

arrow icon

What is the price predicton of CLNN Stock?

arrow icon

What is Clene Inc. (CLNN)'s revenue for the last quarter?

arrow icon

What is Clene Inc. (CLNN)'s earnings per share (EPS) for the last quarter?

arrow icon

What changes have occurred in the market's expectations for Clene Inc. (CLNN)'s fundamentals?

arrow icon

How many employees does Clene Inc. (CLNN). have?

arrow icon

What is Clene Inc. (CLNN) market cap?